United Therapeutics (UTHR) Return on Sales (2016 - 2025)
Historic Return on Sales for United Therapeutics (UTHR) over the last 17 years, with Q3 2025 value amounting to 0.42%.
- United Therapeutics' Return on Sales rose 100.0% to 0.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.53%, marking a year-over-year increase of 100.0%. This contributed to the annual value of 0.42% for FY2024, which is 100.0% down from last year.
- According to the latest figures from Q3 2025, United Therapeutics' Return on Sales is 0.42%, which was up 100.0% from 0.39% recorded in Q2 2025.
- United Therapeutics' 5-year Return on Sales high stood at 217.1% for Q4 2023, and its period low was 38.14% during Q4 2024.
- Its 5-year average for Return on Sales is 9.76%, with a median of 0.41% in 2025.
- In the last 5 years, United Therapeutics' Return on Sales soared by 2168300bps in 2023 and then crashed by -2552400bps in 2024.
- Quarter analysis of 5 years shows United Therapeutics' Return on Sales stood at 0.27% in 2021, then dropped by -1bps to 0.27% in 2022, then soared by 80676bps to 217.1% in 2023, then tumbled by -118bps to 38.14% in 2024, then soared by 101bps to 0.42% in 2025.
- Its last three reported values are 0.42% in Q3 2025, 0.39% for Q2 2025, and 0.41% during Q1 2025.